In a recent study, researchers at Emory University found that depressed patients who did not respond to antidepressants showed more inflammation.
The finding shows that antidepressant treatment resistance is linked to increased inflammatory markers in patients with depression.
Depression affects approximately 10% of the adult population in the United States and is the leading cause of disability worldwide.
Currently, one-third of patients with depression fail to respond to available antidepressant medications.
Previous studies have shown that inflammation has effects on the brain that can undermine the effectiveness of conventional antidepressants.
But this is one of the first studies in humans that confirms these findings.
Levels of inflammation can be easily measured by simple blood tests, like C-reactive protein (CRP), readily available in clinics and hospitals throughout the U.S.
If a patient’s inflammation level is high (CRP>3mg/L), drugs that affect dopamine such as bupropion may be more effective for their depression than drugs that affect serotonin, the usual drugs prescribed.
Patients who have tried and not responded to multiple antidepressants can ask their doctors if inflammation might be the cause.
Ways to reduce inflammation include weight loss and exercise.
Anti-inflammatory drugs are being tested for depression with some early promising results, but they are not approved for use at this time.
During the study, the researchers measured blood concentrations of inflammatory molecules in 98 unmedicated patients with depression.
These patients had experienced varying numbers of failed antidepressant treatment trials in their current depressive episode.
Several inflammation molecules were associated with the number of failed treatment trials.
For example, individuals failing two or three trials had significant elevations in the inflammatory cytokines tumor necrosis factor and its receptor as well as interleukin 6.
CRP was also higher in individuals with a greater number of treatment failures, but only when obesity was not included in statistical analyses. Obesity is highly related to CRP.
The first author Ebrahim Haroon, MD, is the Assistant Professor of psychiatry and biomedical engineering at Emory University.
The study is published in the journal Psychoneuroendocrinology.
Copyright © 2018 Knowridge Science Report. All rights reserved.
Source: Psychoneuroendocrinology.
